SMTL ID : 4zbr.1

Crystal Structure of Equine Serum Albumin in complex with Diclofenac and Naproxen

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.19 Å

Oligo State

monomer

Ligands

1 x DIF: 2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID(Non-covalent)

DIF.1: 9 residues within 4Å: Chain A: L.393, D.401, N.404, A.405, V.408, R.409, K.540, E.541, K.544 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.393, A:N.404, A:K.540, A:E.541, A:K.544, A:K.544, A:K.544 Salt bridges: A:R.409, A:K.540

2 x NPS: (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid(Non-covalent)

NPS.2: 15 residues within 4Å: Chain A: L.386, N.390, C.391, F.402, L.406, R.409, Y.410, K.413, L.429, G.433, C.437, S.448, L.452, R.484, S.488 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.386, A:N.390, A:F.402, A:L.406, A:L.406, A:L.452, A:L.452 Hydrogen bonds: A:Y.410 Water bridges: A:K.413 Salt bridges: A:R.409, A:K.413 pi-Cation interactions: A:R.409 NPS.3: 11 residues within 4Å: Chain A: R.208, A.212, D.323, L.326, L.346, A.349, K.350, S.479, L.480, A.481 Ligands: MLI.11 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:A.212, A:L.346, A:A.349, A:K.350, A:L.480, A:A.481 Hydrogen bonds: A:L.480, A:A.481 Salt bridges: A:K.350 pi-Cation interactions: A:K.350

1 x SIN: SUCCINIC ACID(Non-covalent)

SIN.4: 7 residues within 4Å: Chain A: Y.149, L.237, R.256, I.263, S.286, I.289, A.290 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.237, A:I.289, A:A.290 Hydrogen bonds: A:Y.149 Salt bridges: A:R.256

2 x LMR: (2S)-2-hydroxybutanedioic acid(Non-covalent)

LMR.5: 6 residues within 4Å: Chain A: K.194, W.213, R.217, N.450, H.451, L.454 12 PLIP interactions: 12 interactions with chain A Hydrogen bonds: A:R.217, A:R.217, A:N.450 Water bridges: A:K.194, A:K.194, A:K.221, A:K.221, A:A.290 Salt bridges: A:K.194, A:K.194, A:R.217, A:H.451 LMR.6: 8 residues within 4Å: Chain A: L.189, L.190, A.193, T.428, L.454, A.455, R.458 Ligands: ACT.8 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:T.428 Water bridges: A:A.193, A:H.451

2 x ACT: ACETATE ION(Non-functional Binders)

ACT.7: 4 residues within 4Å: Chain A: P.415, Q.416, K.499, K.533 3 PLIP interactions: 3 interactions with chain A Water bridges: A:T.419 Salt bridges: A:K.499, A:K.533 ACT.8: 5 residues within 4Å: Chain A: K.431, V.432, R.435, H.451 Ligands: LMR.6 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:K.431 Salt bridges: A:R.435, A:H.451

2 x FMT: FORMIC ACID(Non-functional Binders)

FMT.9: 6 residues within 4Å: Chain A: Y.30, H.67, G.71, E.95, R.98, N.99 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.30, A:E.95 FMT.10: 4 residues within 4Å: Chain A: L.115, R.144, H.145, K.185 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.145

1 x MLI: MALONATE ION(Non-functional Binders)

MLI.11: 5 residues within 4Å: Chain A: R.208, A.212, V.215, G.327 Ligands: NPS.3 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sekula, B. et al., Structural Insights into the Competitive Binding of Diclofenac and Naproxen by Equine Serum Albumin. J.Med.Chem. (2016)

Release Date

2015-12-23

Peptides

Serum albumin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serum albumin

Related Entries With Identical Sequence